Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NEL, Nikola, Tesla - is the world facing a new billion-dollar scandal?

The Kiel Institute for the World Economy (IfW) is a renowned organization focusing on research, economic policy advice and analysis. It sees itself as the research institute for globalisation issues in Germany. The institute cooperates worldwide with universities, research ins...

GBP/USD – Pound Gaining Ground as Boris Holds Lead in Polls

It’s Election Day across the U.K, and millions of voters will determine what happens next with the Brexit saga, which has lasted three years. If Prime Minister Johnson can win an outright majority, the British pound could respond with significant gains. ...

Investors Run From Stocks At Record Pace

BIGGEST WITHDRAWALS ON RECORD There is a lot of relevant information in the text below from a Wall Street Journal article dated December 8, 2019 : “Investors have pulled $135.5 billion from U.S. stock-focused mutual funds and exchange-traded funds so far this year, th...

AIM ImmunoTech Shares Soar as Japan's NIID Tests Ampligen® as Potential Coronavirus Treatment

Shares of AIM ImmunoTech traded more than 150% higher after the company reported that Japan's National Institute of Infectious Diseases will test its Ampligen® drug as a potential treatment for the coronavirus. Immuno-pharmaceutical company AIM Imm...

Kiniksa Shares Trade Up 30% on COVID-19 Pneumonia and Hyperinflammation Treatment

Shares of Kiniksa Pharmaceuticals traded higher after the company reported early success in treatment response for mavrilimumab in six patients with severe COVID-19 pneumonia and hyperinflammation. This morning, Hamilton, Bermuda based biopharmaceutical comp...

2023, the dawn of the silver boom

By Chen Lin, chenpicks.com This year saw another year of the huge supply-demand deficit in silver, despite heavy investment selling. The most significant demand increase came from solar panels. In 2021, the Silver Institute and Metal Focus group were looking at PV (...

Does this Device Solve the Issue of Electromagnetic Radiation?

There is a large health issue that few know about and does not see much press, but it is there for everyone to see buried in the fine print when you buy most cell phones. I am talking about electromagnetic radiation (EMR) that is emitted with electronic devices, such as...

Should We Rethink Nuclear Power?

While it seems to fly in the face of everything we believe and have been taught about nuclear power, it may actually be the safest form of power production that we have. Ironically, the immense potency of the power of splitting an atom is simultaneously what makes nuclear weap...

Oil Price Fundamental Daily Forecast – U.S. Supply Will Control Price Action This Week

The late price behavior on Friday and early Monday suggests crude oil traders have fully priced in the Phase One trade agreement. This means that investors will be looking for further news to push prices through the important technical resistance levels in order to extend the...

Oil Price Fundamental Daily Forecast – Speculative Buyers Betting on Increasing Demand Growth

The momentum is currently to the upside and could pick up speed if speculators, betting on increased demand, can drive prices through last week’s highs with conviction. James Hyerczyk U.S. We...
1 2 3 4 5 6 7 8 9 10 ...